PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1462721
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1462721
High-flow Nasal Cannula Market Forecasts to 2030 - Global Analysis By Component, Sales Channel, Application, End User and By Geography
According to Stratistics MRC, the Global High-flow Nasal Cannula Market is accounted for $7.7 billion in 2023 and is expected to reach $19.27 billion by 2030 growing at a CAGR of 14% during the forecast period. A high-flow nasal cannula is a respiratory therapy device that delivers heated and humidified oxygen at high flow rates through small nasal prongs. This therapy is used to treat patients with acute respiratory failure by providing precise oxygenation levels while offering comfort and reducing the work of breathing. The warmed and humidified gas mixture enhances patient tolerance and mobilization, while the high flow rates help to splint open airways, decrease airway resistance, and potentially reduce the need for invasive mechanical ventilation.
According to the World Health Organization It is estimated that 235 million people worldwide have asthma.
Market Dynamics:
Driver:
Rising prevalence of respiratory disorders
Respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and acute respiratory distress syndrome (ARDS) have been on the rise globally. These conditions often require effective oxygen therapy to alleviate respiratory distress and improve patient outcomes. High-flow nasal cannulas deliver a higher flow rate of oxygen compared to traditional oxygen therapy methods, making them particularly beneficial for patients with respiratory disorders. Moreover, they provide a constant and adjustable supply of oxygen, ensuring adequate oxygenation and reducing the workload on the patient's respiratory system.
Restraint:
High cost
HFNC systems can be relatively expensive compared to traditional oxygen therapy methods, which can pose financial challenges for healthcare providers. The initial investment required to purchase the HFNC system, including the flow generator and heated humidifier, can be substantial. The need for regular maintenance and calibration of the equipment further adds to the financial burden, which in turn limits market growth.
Opportunity:
Technological advancements
Ongoing innovations and improvements in HFNC technology have enhanced its performance, safety, and patient comfort, driving increased adoption and utilization. Innovations in flow generators, heated humidifiers, and nasal cannula design have enhanced the performance and comfort of HFNC therapy. Furthermore, manufacturers have introduced soft, flexible, and anatomically contoured nasal cannulas that enhance patient comfort and reduce skin irritation. These advancements in cannula design also contribute to better oxygen delivery and reduce the risk of nasal trauma.
Threat:
Competition from alternative respiratory support therapies
The high-flow nasal cannula (HFNC) market faces restraints due to competition from alternative respiratory support therapies. Non-invasive ventilation, delivered through devices such as bi-level positive airway pressure (BiPAP) or continuous positive airway pressure (CPAP) provides varying levels of pressure support to assist breathing in patients with respiratory failure. Furthermore, invasive mechanical ventilation, involving end tracheal intubation and mechanical ventilator support, is often required for patients with severe respiratory distress or acute respiratory failure.
Covid-19 Impact
The COVID-19 pandemic has significantly impacted the high-flow nasal cannula (HFNC) market by increasing the demand for respiratory support devices to treat patients with severe respiratory symptoms, particularly those suffering from COVID-19-related respiratory distress. Moreover, due to its ability to deliver high-flow oxygen therapy while maintaining optimal airway hydration and reducing the need for invasive ventilation, HFNC has become a preferred option for treating COVID-19 patients, especially those experiencing acute respiratory failure or acute respiratory distress syndrome (ARDS).
The nasal cannula segment is expected to be the largest during the forecast period
The nasal cannula segment is estimated to hold the largest share. The nasal cannula consists of soft prongs that are inserted into the patient's nostrils, along with tubing connected to a specialized device that regulates the flow of oxygen. The high flow rate, combined with the heated and humidified oxygen, helps maintain optimal airway hydration, reduces mucosal irritation, and improves patient comfort. The high-flow nasal cannula market has experienced significant growth due to its effectiveness in delivering oxygen therapy, improving patient outcomes, and enhancing comfort compared to traditional methods.
The acute respiratory failure segment is expected to have the highest CAGR during the forecast period
The acute respiratory failure segment is anticipated to have lucrative growth during the forecast period. By delivering a precisely regulated flow of warm and humidified oxygen, HFNCs improve patient comfort, reduce airway resistance, and decrease the work of breathing. These factors are particularly beneficial in the management of ARF, where patients often experience respiratory distress and discomfort. Furthermore, HFNC therapy can prevent the need for invasive mechanical ventilation in some ARF cases, thereby reducing the risks associated with intubation and its complications.
Region with largest share:
North America commanded the largest market share during the extrapolated period owing to due to its efficacy in delivering high-flow oxygen therapy to patients with respiratory issues. This region boasts advanced healthcare infrastructure and a high prevalence of chronic respiratory diseases, driving the demand for HFNC systems. Additionally, the region's aging population and the incidence of conditions like chronic obstructive pulmonary disease (COPD) and sleep apnea further fuel the adoption of HFNC therapy.
Region with highest CAGR:
Asia Pacific is expected to witness profitable growth over the projection period, owing to the lifestyle changes. Rising pollution levels, tobacco consumption, and an aging population contribute to the growing prevalence of conditions like chronic obstructive pulmonary disease (COPD) and respiratory infections, necessitating effective respiratory support systems such as HFNCs. Moreover, improving healthcare infrastructure, expanding access to healthcare services, and increasing healthcare expenditure further stimulate the demand for advanced respiratory care devices in APAC.
Key players in the market
Some of the key players in the High-flow Nasal Cannula Market include Becton, Dickinson and Company, Fisher & Paykel Healthcare Corporation Ltd., Flexicare Medical Ltd., Great Group Medical Co., Ltd., Hamilton Medical AG, MEK-ICS Co., Ltd., Resmed Inc., Salter Labs Inc., Smiths Medical, Teijin Pharma Ltd., Teleflex, Inc., TNI Medical AG and Vapotherm, Inc.
Key Developments:
In January 2024, BD (Becton, Dickinson and Company) and Techcyte announced a strategic collaboration agreement to offer an AI-based algorithm that guides cytologists and pathologists to efficiently and effectively identify evidence of cervical cancer and pre cancer using whole-slide imaging.
In November 2023, Teijin Limited announced that the company has entered into an exclusive license agreement with Ascendis Pharma A/S for the further development and commercialization of TransCon hGH, TransCon PTH, and TransCon CNP for endocrinology rare disease in Japan.
In March 2023, Becton Dickinson and the Agency for Science, Technology and Research have announced an extended research partnership that will focus on deep immune phenotyping of human tissues using spectral flow cytometry panels to bring forth discoveries that can be translated into positive healthcare outcomes.
Components Covered:
- Air Humidifier
- Nasal Cannula
- Single Heated Tube
- Air/Oxygen Blend
- Other Components
Sales Channels Covered:
- Distributor Sales
- Direct Sales
Applications Covered:
- Acute Respiratory Failure
- Sleep Apnea
- Carbon Monoxide Toxicity
- Acute Respiratory Failure
- Bronchiectasis
- Chronic Obstructive Pulmonary Disease (COPD)
- Other Applications
End Users Covered:
- Tomosynthesis
- Ambulatory Care Centers
- Hospitals
- Long-term Care Centers
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Application Analysis
- 3.7 End User Analysis
- 3.8 Emerging Markets
- 3.9 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global High Flow Nasal Cannula Market, By Component
- 5.1 Introduction
- 5.2 Air Humidifier
- 5.3 Nasal Cannula
- 5.4 Single Heated Tube
- 5.5 Air/Oxygen Blend
- 5.6 Other Components
6 Global High Flow Nasal Cannula Market, By Sales Channel
- 6.1 Introduction
- 6.2 Distributor Sales
- 6.3 Direct Sales
7 Global High Flow Nasal Cannula Market, By Application
- 7.1 Introduction
- 7.2 Acute Respiratory Failure
- 7.3 Sleep Apnea
- 7.4 Carbon Monoxide Toxicity
- 7.5 Acute Respiratory Failure
- 7.6 Bronchiectasis
- 7.7 Chronic Obstructive Pulmonary Disease (COPD)
- 7.8 Other Applications
8 Global High Flow Nasal Cannula Market, By End User
- 8.1 Introduction
- 8.2 Tomosynthesis
- 8.3 Ambulatory Care Centers
- 8.4 Hospitals
- 8.5 Long-term Care Centers
- 8.6 Other End Users
9 Global High Flow Nasal Cannula Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
11 Company Profiling
- 11.1 Becton, Dickinson and Company
- 11.2 Fisher & Paykel Healthcare Corporation Ltd.
- 11.3 Flexicare Medical Ltd.
- 11.4 Great Group Medical Co., Ltd.
- 11.5 Hamilton Medical AG
- 11.6 MEK-ICS Co., Ltd.
- 11.7 Resmed Inc.
- 11.8 Salter Labs Inc.
- 11.9 Smiths Medical
- 11.10 Teijin Pharma Ltd.
- 11.11 Teleflex, Inc.
- 11.12 TNI Medical AG
- 11.13 Vapotherm, Inc.
List of Tables
- Table 1 Global High Flow Nasal Cannula Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
- Table 3 Global High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
- Table 4 Global High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
- Table 5 Global High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
- Table 6 Global High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
- Table 7 Global High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
- Table 8 Global High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
- Table 9 Global High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
- Table 10 Global High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
- Table 11 Global High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
- Table 12 Global High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
- Table 13 Global High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
- Table 14 Global High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
- Table 15 Global High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
- Table 16 Global High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
- Table 17 Global High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
- Table 18 Global High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 19 Global High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
- Table 20 Global High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
- Table 21 Global High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
- Table 22 Global High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 23 Global High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
- Table 24 Global High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 25 North America High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
- Table 26 North America High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
- Table 27 North America High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
- Table 28 North America High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
- Table 29 North America High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
- Table 30 North America High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
- Table 31 North America High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
- Table 32 North America High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
- Table 33 North America High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
- Table 34 North America High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
- Table 35 North America High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
- Table 36 North America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
- Table 37 North America High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
- Table 38 North America High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
- Table 39 North America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
- Table 40 North America High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
- Table 41 North America High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
- Table 42 North America High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 43 North America High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
- Table 44 North America High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
- Table 45 North America High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
- Table 46 North America High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 47 North America High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
- Table 48 North America High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 49 Europe High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
- Table 50 Europe High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
- Table 51 Europe High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
- Table 52 Europe High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
- Table 53 Europe High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
- Table 54 Europe High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
- Table 55 Europe High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
- Table 56 Europe High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
- Table 57 Europe High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
- Table 58 Europe High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
- Table 59 Europe High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
- Table 60 Europe High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
- Table 61 Europe High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
- Table 62 Europe High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
- Table 63 Europe High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
- Table 64 Europe High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
- Table 65 Europe High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
- Table 66 Europe High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 67 Europe High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
- Table 68 Europe High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
- Table 69 Europe High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
- Table 70 Europe High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 71 Europe High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
- Table 72 Europe High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 73 Asia Pacific High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
- Table 74 Asia Pacific High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
- Table 75 Asia Pacific High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
- Table 76 Asia Pacific High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
- Table 77 Asia Pacific High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
- Table 78 Asia Pacific High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
- Table 79 Asia Pacific High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
- Table 80 Asia Pacific High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
- Table 81 Asia Pacific High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
- Table 82 Asia Pacific High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
- Table 83 Asia Pacific High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
- Table 84 Asia Pacific High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
- Table 85 Asia Pacific High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
- Table 86 Asia Pacific High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
- Table 87 Asia Pacific High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
- Table 88 Asia Pacific High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
- Table 89 Asia Pacific High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
- Table 90 Asia Pacific High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 91 Asia Pacific High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
- Table 92 Asia Pacific High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
- Table 93 Asia Pacific High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
- Table 94 Asia Pacific High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 95 Asia Pacific High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
- Table 96 Asia Pacific High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 97 South America High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
- Table 98 South America High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
- Table 99 South America High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
- Table 100 South America High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
- Table 101 South America High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
- Table 102 South America High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
- Table 103 South America High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
- Table 104 South America High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
- Table 105 South America High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
- Table 106 South America High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
- Table 107 South America High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
- Table 108 South America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
- Table 109 South America High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
- Table 110 South America High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
- Table 111 South America High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
- Table 112 South America High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
- Table 113 South America High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
- Table 114 South America High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 115 South America High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
- Table 116 South America High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
- Table 117 South America High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
- Table 118 South America High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 119 South America High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
- Table 120 South America High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 121 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Country (2021-2030) ($MN)
- Table 122 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Component (2021-2030) ($MN)
- Table 123 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Air Humidifier (2021-2030) ($MN)
- Table 124 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Nasal Cannula (2021-2030) ($MN)
- Table 125 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Single Heated Tube (2021-2030) ($MN)
- Table 126 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Air/Oxygen Blend (2021-2030) ($MN)
- Table 127 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Other Components (2021-2030) ($MN)
- Table 128 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Sales Channel (2021-2030) ($MN)
- Table 129 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Distributor Sales (2021-2030) ($MN)
- Table 130 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Direct Sales (2021-2030) ($MN)
- Table 131 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Application (2021-2030) ($MN)
- Table 132 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
- Table 133 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Sleep Apnea (2021-2030) ($MN)
- Table 134 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Carbon Monoxide Toxicity (2021-2030) ($MN)
- Table 135 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Acute Respiratory Failure (2021-2030) ($MN)
- Table 136 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Bronchiectasis (2021-2030) ($MN)
- Table 137 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
- Table 138 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Other Applications (2021-2030) ($MN)
- Table 139 Middle East & Africa High Flow Nasal Cannula Market Outlook, By End User (2021-2030) ($MN)
- Table 140 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Tomosynthesis (2021-2030) ($MN)
- Table 141 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Ambulatory Care Centers (2021-2030) ($MN)
- Table 142 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 143 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Long-term Care Centers (2021-2030) ($MN)
- Table 144 Middle East & Africa High Flow Nasal Cannula Market Outlook, By Other End Users (2021-2030) ($MN)
